These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9292436)

  • 1. Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers.
    Lorenzo-Lamosa ML; Cuña M; Vila-Jato JL; Torres D; Alonso MJ
    J Microencapsul; 1997; 14(5):607-16. PubMed ID: 9292436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. Part 1: the influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres.
    Robson HJ; Craig DQ; Deutsch D
    Int J Pharm; 1999 Nov; 190(2):183-92. PubMed ID: 10547458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. III. The use of DSC and HSDSC as means of characterising the interaction of the microspheres with buffered media.
    Robson H; Craig DQ; Deutsch D
    Int J Pharm; 2000 May; 201(2):211-9. PubMed ID: 10878327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyacrylate resin microcapsules for taste masking of antibiotics.
    Friend DR
    J Microencapsul; 1992; 9(4):469-80. PubMed ID: 1403495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing a self-associated cationic polymer for enhanced compatibility, palatability, and gastric release of cefuroxime axetil.
    Menjoge AR; Kulkarni MG
    Biomacromolecules; 2007 Feb; 8(2):532-42. PubMed ID: 17253762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. II. The effects of buffer composition on drug release.
    Robson H; Craig DQ; Deutsch D
    Int J Pharm; 2000 Feb; 195(1-2):137-45. PubMed ID: 10675691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
    Wulff R; Leopold CS
    Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and characterization of cefuroxime axetil biphasic floating minitablets.
    Jammula S; Patra ChN; Swain S; Panigrahi KC; Nayak S; Dinda SC; Rao ME
    Drug Deliv; 2015 Jan; 22(1):125-35. PubMed ID: 24417642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen.
    Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
    J Microencapsul; 1986; 3(4):293-304. PubMed ID: 3508190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity of cationic polymer Eudragit RL to electrolytes and its effect on drug release from Eudragit RL matrix].
    Fu C; Zhao L; Jiang X
    Yao Xue Xue Bao; 1998 Jul; 33(7):538-43. PubMed ID: 12016889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic Eudragit® polymers as excipients for microparticles prepared by solvent evaporation method.
    Vysloužil J; Bavoľárová J; Kejdušová M; Vetchý D; Dvořáčková K
    Ceska Slov Farm; 2013 Dec; 62(6):249-54. PubMed ID: 24393112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eudragit E, L and S (acrylic resins) microcapsules as pH sensitive release preparations of ketoprofen.
    Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
    J Microencapsul; 1986; 3(4):305-16. PubMed ID: 3508191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymers with pH-dependent solubility: possibility of use in the formulation of gastroresistant and controlled-release matrix tablets.
    Palmieri GF; Michelini S; Di Martino P; Martelli S
    Drug Dev Ind Pharm; 2000 Aug; 26(8):837-45. PubMed ID: 10900540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
    Kibria G; Islam KM; Jalil RU
    Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres.
    Momoh MA; Kenechukwu FC; Adedokun MO; Odo CE; Attama AA
    Drug Deliv; 2014 May; 21(3):193-203. PubMed ID: 24171400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles.
    Shastri PN; Ubale RV; D'Souza MJ
    Drug Dev Ind Pharm; 2013 Feb; 39(2):164-75. PubMed ID: 22591196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.